Literature DB >> 15345531

Michaelis-Menten kinetics under spatially constrained conditions: application to mibefradil pharmacokinetics.

Kosmas Kosmidis1, Vangelis Karalis, Panos Argyrakis, Panos Macheras.   

Abstract

Two different approaches were used to study the kinetics of the enzymatic reaction under heterogeneous conditions to interpret the unusual nonlinear pharmacokinetics of mibefradil. Firstly, a detailed model based on the kinetic differential equations is proposed to study the enzymatic reaction under spatial constraints and in vivo conditions. Secondly, Monte Carlo simulations of the enzyme reaction in a two-dimensional square lattice, placing special emphasis on the input and output of the substrate were applied to mimic in vivo conditions. Both the mathematical model and the Monte Carlo simulations for the enzymatic reaction reproduced the classical Michaelis-Menten (MM) kinetics in homogeneous media and unusual kinetics in fractal media. Based on these findings, a time-dependent version of the classic MM equation was developed for the rate of change of the substrate concentration in disordered media and was successfully used to describe the experimental plasma concentration-time data of mibefradil and derive estimates for the model parameters. The unusual nonlinear pharmacokinetics of mibefradil originates from the heterogeneous conditions in the reaction space of the enzymatic reaction. The modified MM equation can describe the pharmacokinetics of mibefradil as it is able to capture the heterogeneity of the enzymatic reaction in disordered media.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15345531      PMCID: PMC1304557          DOI: 10.1529/biophysj.104.042143

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  22 in total

1.  Anomalous diffusion of fluorescent probes inside living cell nuclei investigated by spatially-resolved fluorescence correlation spectroscopy.

Authors:  M Wachsmuth; W Waldeck; J Langowski
Journal:  J Mol Biol       Date:  2000-05-12       Impact factor: 5.469

2.  Monte carlo simulations of enzyme reactions in two dimensions: fractal kinetics and spatial segregation.

Authors:  Hugues Berry
Journal:  Biophys J       Date:  2002-10       Impact factor: 4.033

3.  Dynamics, structure, and function are coupled in the mitochondrial matrix.

Authors:  B A Scalettar; J R Abney; C R Hackenbrock
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

4.  Development of fractal kinetic theory for enzyme-catalysed reactions and implications for the design of biochemical pathways.

Authors:  M A Savageau
Journal:  Biosystems       Date:  1998 Jun-Jul       Impact factor: 1.973

Review 5.  Molecular crowding: analysis of effects of high concentrations of inert cosolutes on biochemical equilibria and rates in terms of volume exclusion.

Authors:  A P Minton
Journal:  Methods Enzymol       Date:  1998       Impact factor: 1.600

6.  Anomalous diffusion of water in biological tissues.

Authors:  M Köpf; C Corinth; O Haferkamp; T F Nonnenmacher
Journal:  Biophys J       Date:  1996-06       Impact factor: 4.033

7.  Application of fractal kinetics for carrier-mediated transport of drugs across intestinal epithelial membrane.

Authors:  T Ogihara; I Tamai; A Tsuji
Journal:  Pharm Res       Date:  1998-04       Impact factor: 4.200

8.  The application of a fractal model to the scattering of ultrasound in biological media.

Authors:  C Javanaud
Journal:  J Acoust Soc Am       Date:  1989-08       Impact factor: 1.840

9.  Macromolecular crowding and molecular recognition.

Authors:  A P Minton
Journal:  J Mol Recognit       Date:  1993-12       Impact factor: 2.137

10.  Nonlinear pharmacokinetics of mibefradil in the dog.

Authors:  A Skerjanec; S Tawfik; Y K Tam
Journal:  J Pharm Sci       Date:  1996-02       Impact factor: 3.534

View more
  10 in total

Review 1.  Advanced pharmacokinetic models based on organ clearance, circulatory, and fractal concepts.

Authors:  K Sandy Pang; Michael Weiss; Panos Macheras
Journal:  AAPS J       Date:  2007-06-29       Impact factor: 4.009

2.  Fractional kinetics in drug absorption and disposition processes.

Authors:  Aristides Dokoumetzidis; Panos Macheras
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-04-02       Impact factor: 2.745

3.  A new approach to the compartmental analysis in pharmacokinetics: fractional time evolution of diclofenac.

Authors:  Jovan K Popović; Milica T Atanacković; Ana S Pilipović; Milan R Rapaić; Stevan Pilipović; Teodor M Atanacković
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-01-14       Impact factor: 2.745

4.  The changing face of the rate concept in biopharmaceutical sciences: from classical to fractal and finally to fractional.

Authors:  Aristides Dokoumetzidis; Panos Macheras
Journal:  Pharm Res       Date:  2011-01-25       Impact factor: 4.200

Review 5.  Monte Carlo simulations in drug release.

Authors:  Kosmas Kosmidis; George Dassios
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-03-18       Impact factor: 2.745

6.  Interpreting airborne pandemics spreading using fractal kinetics' principles.

Authors:  Panos Macheras; Athanasios A Tsekouras; Pavlos Chryssafidis
Journal:  F1000Res       Date:  2021-07-20

7.  Fractal michaelis-menten kinetics under steady state conditions: Application to mibefradil.

Authors:  Rebeccah E Marsh; Jack A Tuszyński
Journal:  Pharm Res       Date:  2006-10-25       Impact factor: 4.580

8.  A physiologically-based flow network model for hepatic drug elimination II: variable lattice lobule models.

Authors:  Vahid Rezania; Rebeccah Marsh; Dennis Coombe; Jack Tuszynski
Journal:  Theor Biol Med Model       Date:  2013-09-05       Impact factor: 2.432

9.  Extensions to Michaelis-Menten Kinetics for Single Parameters.

Authors:  R T K Ariyawansha; B F A Basnayake; A K Karunarathna; M I M Mowjood
Journal:  Sci Rep       Date:  2018-11-08       Impact factor: 4.379

10.  Application of modified Michaelis - Menten equations for determination of enzyme inducing and inhibiting drugs.

Authors:  Saganuwan Alhaji Saganuwan
Journal:  BMC Pharmacol Toxicol       Date:  2021-10-11       Impact factor: 2.483

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.